Literature DB >> 31408262

Use of 65 cm large caliber Dryseal sheaths to facilitate delivery of the Edwards SAPIEN valve to dysfunctional right ventricular outflow tracts.

Damien Kenny1,2, Gareth J Morgan3,4, Matthew Murphy2, Khalid AlAlwi1, Luca Giugno5, Jenny Zablah3, Mario Carminati5, Kevin Walsh1,2.   

Abstract

BACKGROUND: The Edwards SAPIEN valve and its delivery system may complicate transit through the right heart during transcatheter pulmonary valve replacement (tPVR). We report our early experience using a large diameter, 65 cm delivery sheath to facilitate delivery of the SAPIEN valve to the right ventricular outflow tract (RVOT).
METHODS: Retrospective analysis of all patients from three large congenital heart centers undergoing tPVR with the Edwards SAPIEN valve delivered with the 65 cm Gore Dryseal Sheath.
RESULTS: Over a 12 month period, 30 patients (17 female) with median age 17.5 years (range 8-72) underwent attempted tPVR with the SAPIEN valve delivered using the 65 cm Dryseal sheath (20-26Fr). All procedures resulted in successful valve delivery to the target area. Twenty patients had a native RVOT. The most commonly used valve diameter was 29 mm (n = 15) with the majority of cases requiring a 26Fr Dryseal sheath (n = 20). One patient with severe RVOT stenosis underwent prestenting. Median procedure time was 100 min (59-225). No patient had increase in tricuspid valve regurgitation as a consequence of valve delivery. One patient required a synchronous cardioversion for intraprocedural VT and another required ECMO postprocedure due to severe pre-existing left ventricular dysfunction. On median follow-up of 5 months, all patients had mild or less pulmonary regurgitation. Median peak Doppler velocity across the pulmonary valve was 2.2 m/s (1.7-4). There were no clinically relevant complications relating to vascular access.
CONCLUSIONS: Using 65 cm Dryseal sheaths facilitates delivery of SAPIEN valves in patients with dysfunctional RVOTs.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  COMV, complications; PEDI, pediatric intervention; PVD, pulmonary valve disease; percutaneous intervention; vascular access

Mesh:

Year:  2019        PMID: 31408262     DOI: 10.1002/ccd.28409

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Transcatheter pulmonic valve implantation in adult patients with prior congenital heart surgery.

Authors:  Zachary A Spigel; Iki Adachi; Ziyad M Binsalamah; Dhaval Parekh; Athar M Qureshi
Journal:  Ann Cardiothorac Surg       Date:  2021-09

2.  Transcatheter Systemic AV Valve-in-Valve Implantation in a Patient With LTGA and Ebstein Anomaly.

Authors:  Islam Abudayyeh; George P Jolly; Michael A Kuhn; Brent M Gordon
Journal:  JACC Case Rep       Date:  2022-05-04

Review 3.  Transcatheter pulmonic valve implantation: Techniques, current roles, and future implications.

Authors:  Mark Aaron Law; Arka Chatterjee
Journal:  World J Cardiol       Date:  2021-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.